IP Verse

Taiho Pharmaceutical Co., Ltd. opposition analysis

COMPANY ANALYSIS

Latest patents of Taiho Pharmaceutical Co., Ltd. opposed by its competitors

Patent:
EP1849470
Grant Date:
Mar 20, 2024
Title:
Anticancer Drug Containing Alpha, Alpha, Alphatrifluorothymidine And Thymidine Phosphorylase Inhibitor
Oppositions:
2
Patent:
EP3042669
Grant Date:
Mar 8, 2023
Title:
Antitumor Agent And Antitumor Effect Enhancer
Oppositions:
2
Patent:
EP3012255
Grant Date:
Oct 13, 2021
Title:
Stabilized Crystal Of Tipiracil Hydrochloride, And Crystallization Method For Same
Oppositions:
1
Patent:
EP2815752
Grant Date:
May 20, 2020
Title:
Oral Pharmaceutical Composition
Oppositions:
1
Patent:
EP2815753
Grant Date:
May 16, 2018
Title:
Oral Pharmaceutical Composition
Oppositions:
1

Competitors of Taiho Pharmaceutical Co., Ltd.

GENERICS (U.K.) LIMITED

STADA ARZNEIMITTEL AG

CAMULON LIMITED

Want to track Taiho Pharmaceutical Co., Ltd.?

Feel free to send us a message here and we will get back to you